Similar articles for PMID: 15308518

Year	Number of Results
1945	1
1957	1
1962	1
1963	3
1964	1
1965	2
1973	1
1975	1
1977	1
1979	1
1982	1
1983	2
1984	1
1985	2
1987	1
1988	1
1990	1
1991	1
1993	1
1994	1
1995	6
1996	4
1997	1
1998	3
1999	2
2000	5
2001	5
2002	4
2003	8
2004	16
2005	21
2006	20
2007	32
2008	25
2009	19
2010	20
2011	16
2012	18
2013	13
2014	23
2015	15
2016	21
2017	20
2018	16
2019	14
2020	11
2021	14
2022	3
2024	0

1

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B; BARFOT Study Group. Forslind K, et al. Ann Rheum Dis. 2004 Sep;63(9):1090-5. doi: 10.1136/ard.2003.014233. Ann Rheum Dis. 2004. PMID: 15308518 Free PMC article.

2

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.

Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S. Berglin E, et al. Ann Rheum Dis. 2006 Apr;65(4):453-8. doi: 10.1136/ard.2005.041376. Epub 2005 Sep 21. Ann Rheum Dis. 2006. PMID: 16176994 Free PMC article.

3

Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.

Kaltenhäuser S, Pierer M, Arnold S, Kamprad M, Baerwald C, Häntzschel H, Wagner U. Kaltenhäuser S, et al. Rheumatology (Oxford). 2007 Jan;46(1):100-4. doi: 10.1093/rheumatology/kel052. Epub 2006 May 25. Rheumatology (Oxford). 2007. PMID: 16728439

4

The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.

Reneses S, González-Escribano MF, Fernández-Suárez A, Pestana L, Davila B, Wichmann I, García A. Reneses S, et al. J Rheumatol. 2009 Jun;36(6):1143-9. doi: 10.3899/jrheum.081075. Epub 2009 May 1. J Rheumatol. 2009. PMID: 19411391

5

High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landewé R, Kvien TK. Syversen SW, et al. Ann Rheum Dis. 2008 Feb;67(2):212-7. doi: 10.1136/ard.2006.068247. Epub 2007 May 25. Ann Rheum Dis. 2008. PMID: 17526555

6

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE, de Vries RR. van Gaalen FA, et al. Arthritis Rheum. 2004 Jul;50(7):2113-21. doi: 10.1002/art.20316. Arthritis Rheum. 2004. PMID: 15248208 Free article.

7

Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.

Kuru O, Bilgici A, Birinci A, Ulusoy H, Durupinar B. Kuru O, et al. Bratisl Lek Listy. 2009;110(10):650-4. Bratisl Lek Listy. 2009. PMID: 20017459

8

Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.

Syversen SW, Goll GL, van der Heijde D, Landewé R, Lie BA, Odegård S, Uhlig T, Gaarder PI, Kvien TK. Syversen SW, et al. Ann Rheum Dis. 2010 Feb;69(2):345-51. doi: 10.1136/ard.2009.113092. Epub 2009 Jul 30. Ann Rheum Dis. 2010. PMID: 19648126

9

Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.

Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA. Markatseli TE, et al. J Rheumatol. 2011 Jan;38(1):44-52. doi: 10.3899/jrheum.100514. Epub 2010 Oct 15. J Rheumatol. 2011. PMID: 20952476

10

Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.

Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR. Innala L, et al. J Rheumatol. 2008 Jun;35(6):1002-8. Epub 2008 Apr 1. J Rheumatol. 2008. PMID: 18398946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

337 results

Results by year